Home > Insider Trading > Filing (0001144204-16-105769)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1537561	Arch Therapeutics Inc.	ARTH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1229448	R James Sulat	C/O Arch Therapeutics, Inc. 235 Walnut Street, Suite 6 Framingham MA 01702		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-26	111,111	$0.00	868,934	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series E Warrant to Purchase Common Stock	Acquisiton	2016-05-26	83,333	$0.00	83,333	$0.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
83,333	2016-05-26	2021-05-26	No	4	P	Indirect

Footnotes

The Common Stock and Series E Warrants reported on this Form 4 were sold in the form of Units issued by Arch Therapeutics, Inc. in a private placement conducted on May 26, 2016 at a price of $0.36 per Unit. Each Unit consisted of one share of Common Stock and a Series E Warrant to purchase 0.75 Shares of Common Stock at an exercise price of $0.438 per share.
Held indirectly by the Keyes Sulat Revocable Trust, of which Mr. Sulat and his spouse are the trustees and the members of Mr. Sulat's immediately family are the beneficiaries.
Of the shares of Common Stock underlying the Series E Warrants, all are immediately exercisable.